Clinical trial
Change Asthma Clinical Practice Through Guideline Education and Implementation For All Patients With Asthma: an Evaluation of an Asthma Quality Improvement Program
NCT05440097 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Change Asthma Clinical Practice Through Guideline Education and Implementation For All Patients With Asthma: an Evaluation of an Asthma Quality Improvement Program
- Lead sponsor
- AstraZeneca
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 29, 2022
- Completion date
- September 3, 2024
- Enrollment
- 1,500 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.